Insider Selling: National Health Investors Inc (NYSE:NHI) Director Sells 900 Shares of Stock

National Health Investors Inc (NYSE:NHI) Director James R. Jobe sold 900 shares of the firm’s stock in a transaction on Tuesday, September 24th. The shares were sold at an average price of $83.23, for a total transaction of $74,907.00. Following the completion of the sale, the director now owns 12,052 shares in the company, valued at $1,003,087.96. The sale was disclosed in a document filed with the SEC, which is available at this link.

Shares of NHI traded up $0.33 during midday trading on Wednesday, reaching $83.53. The stock had a trading volume of 136,471 shares, compared to its average volume of 202,437. National Health Investors Inc has a 1-year low of $70.54 and a 1-year high of $84.75. The company’s fifty day simple moving average is $82.45 and its two-hundred day simple moving average is $79.33. The company has a market cap of $3.60 billion, a price-to-earnings ratio of 15.24, a PEG ratio of 3.78 and a beta of 0.33. The company has a debt-to-equity ratio of 1.04, a current ratio of 14.42 and a quick ratio of 14.42.

National Health Investors (NYSE:NHI) last announced its quarterly earnings data on Thursday, August 8th. The real estate investment trust reported $0.92 earnings per share for the quarter, missing the Zacks’ consensus estimate of $1.37 by ($0.45). National Health Investors had a net margin of 50.71% and a return on equity of 11.00%. The firm had revenue of $78.10 million during the quarter, compared to analyst estimates of $77.64 million. During the same quarter in the previous year, the business posted $1.38 earnings per share. National Health Investors’s revenue for the quarter was up 7.0% compared to the same quarter last year. On average, sell-side analysts forecast that National Health Investors Inc will post 5.49 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Friday, November 8th. Investors of record on Monday, September 30th will be paid a dividend of $1.05 per share. The ex-dividend date of this dividend is Friday, September 27th. This represents a $4.20 annualized dividend and a yield of 5.03%. National Health Investors’s dividend payout ratio is currently 76.64%.

A number of large investors have recently made changes to their positions in the stock. Macquarie Group Ltd. raised its stake in National Health Investors by 5.4% during the 2nd quarter. Macquarie Group Ltd. now owns 17,700 shares of the real estate investment trust’s stock worth $1,381,000 after acquiring an additional 900 shares in the last quarter. Royal Bank of Canada raised its stake in National Health Investors by 5.9% during the 2nd quarter. Royal Bank of Canada now owns 57,836 shares of the real estate investment trust’s stock worth $4,514,000 after acquiring an additional 3,204 shares in the last quarter. United Services Automobile Association raised its stake in National Health Investors by 5.9% during the 2nd quarter. United Services Automobile Association now owns 10,029 shares of the real estate investment trust’s stock worth $783,000 after acquiring an additional 561 shares in the last quarter. Equitable Trust Co. raised its stake in National Health Investors by 47.7% during the 2nd quarter. Equitable Trust Co. now owns 6,285 shares of the real estate investment trust’s stock worth $490,000 after acquiring an additional 2,030 shares in the last quarter. Finally, Summit Global Investments raised its stake in National Health Investors by 6.9% during the 2nd quarter. Summit Global Investments now owns 9,300 shares of the real estate investment trust’s stock worth $726,000 after acquiring an additional 600 shares in the last quarter. Hedge funds and other institutional investors own 69.72% of the company’s stock.

Separately, Zacks Investment Research upgraded shares of National Health Investors from a “sell” rating to a “hold” rating in a report on Tuesday. Two equities research analysts have rated the stock with a sell rating and four have assigned a hold rating to the company. The stock has a consensus rating of “Hold” and a consensus price target of $79.60.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.

See Also: Investing in Blue-Chip Stocks

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.